Nucleosides - PDFSEARCH.IO - Document Search Engine

Nucleosides
Results: 119

#	Item
21	DNA demethylation activity over time and safety of 3 different dose-escalation regimens of SGI-110, a novel subcutaneous (SQ) hypomethylating agent (HMA), in the treatment of relapsed/refractory patients with MDS and AML Add to Reading List Source URL: astx.com Language: English Pharmacology Azacitidine lactams Chemistry Decitabine Hypomethylating agent Nucleosides Triazines Medicine
22	Results From the Dose Escalation Phase of a Randomized Phase 1–2 First-in-Human (FIH) Study of SGI-110, a Novel Low Volume Stable Subcutaneous (SQ) Second Generation Hypomethylating Agent (HMA) in Patients with Relapse Add to Reading List Source URL: astx.com Language: English - Date: 2013-05-20 15:28:50 Triazines Epigenetics Biology Acute leukemia Myeloid leukemia Acute myeloid leukemia DNA methyltransferase Azacitidine Decitabine Oncology Medicine Nucleosides
23	Study of the correlation of baseline biomarkers and DNA demethylation to clinical responses in a phase 1/2, randomized study of SGI-110, a novel subcutaneous hypomethylating agent in the treatment of relapsed/refractory Add to Reading List Source URL: astx.com Language: English Medicine Epigenetics Biology Acute leukemia Myeloid leukemia Azacitidine Acute myeloid leukemia Hypomethylating agent Decitabine Oncology Nucleosides Triazines
24	ABST # A190 In Vivo Activity of SGI-110, a Novel Hypomethylating Agent for Treatment in Hematology and Solid Malignancies Jason Scholl, David Vollmer, Jared Bearss, Carissa Jones, Virgil McCarthy, Paul Severson, Sanjeev Add to Reading List Source URL: astx.com Language: English - Date: 2012-12-13 18:06:00 DNA DNA methylation Epigenetics Myelodysplastic syndrome Hypomethylating agent Decitabine Biology Medicine Nucleosides Triazines
25	First clinical results of a randomized phase 2 study of SGI-110, a novel subcutaneous (SQ) hypomethylating agent (HMA), in adult patients with acute myeloid leukemia (AML) Jean Pierre Issa, MD Fels Institute, Temple Univ Add to Reading List Source URL: astx.com Language: English Triazines Acute leukemia Myeloid leukemia Acute myeloid leukemia Orphan drugs Azacitidine DNA methyltransferase Leukemia Epigenetics Oncology Medicine Nucleosides
26	First clinical results of a randomized phase 2 study of SGI-110, a novel subcutaneous hypomethylating agent, in 102 patients with Intermediate or High Risk MDS or CMML On Behalf of the SGI-110 Investigative Team Guillerm Add to Reading List Source URL: astx.com Language: English Pharmacology Azacitidine lactams Chemistry Decitabine Hypomethylating agent DNA methyltransferase Nucleosides Triazines Medicine
27	Microsoft PowerPoint - LLS1104 - MDS slides - on background v14 (for pdf) [Compatibility Mode] Add to Reading List Source URL: www.cancereducation.com Language: English - Date: 2015-04-02 11:28:05 Nucleosides Triazines Immunosuppressants Lenalidomide Azacitidine Decitabine Erythropoietin International Prognostic Scoring System Hypomethylating agent Medicine Oncology Pharmacology
28	11th International Congress on Targeted Anticancer Therapies Paris, March 4-6, 2013 IMMUNOMODULATORY ACTIVITY OF SGI-110, A SECOND GENERATION HYPOMETHYLATING Add to Reading List Source URL: astx.com Language: English Triazines Epigenetics Hypomethylating agent DNA methyltransferase Decitabine Azacitidine DNA methylation Methylation Cell culture Biology Chemistry Nucleosides
29	Microsoft Word - ADENOSINE Add to Reading List Source URL: www.shpa.org.au Language: English - Date: 2014-11-18 18:24:29 Cardiac dysrhythmia Intravenous fluids Adenosine Nucleosides Purines Intravenous therapy Antiarrhythmic agent Tachycardia Supraventricular tachycardia Medicine Pharmacology Cardiology
30	2015_SGI-110_Poster_PW-01_QP-05_ASCPT_Oganesian_Final_2 Add to Reading List Source URL: astx.com Language: English - Date: 2015-03-06 15:22:40 Nucleosides Triazines Medicine Acute myeloid leukemia Decitabine Hypomethylating agent Leukemia Oncology Acute leukemia Myeloid leukemia

UPDATE